Dow Up 0.12% Nasdaq Up 1.35%

AbbVie Inc. (ABBV)

-NYQ
54.41 Up 1.04(1.95%) 4:00PM EDT
|After Hours : 55.65 Up 1.24 (2.28%) 6:34PM EDT
Prev Close:53.37
Open:52.25
Bid:55.51 x 200
Ask:55.60 x 500
1y Target Est:64.80
Beta:1.928
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:52.25 - 54.59
52wk Range:45.50 - 60.02
Volume:17,953,937
Avg Vol (3m):14,679,400
Market Cap:86.60B
P/E (ttm):21.09
EPS (ttm):2.58
Div & Yield:1.68 (3.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVUp 1.95%86.60B
MRKUp 0.06%155.91B
NVSUp 1.47%213.26B
PFEUp 0.36%177.10B

Key Statistics

Forward P/E (1 yr):13.95
P/S (ttm):4.41
Ex-Dividend Date:10-Oct-14

Analysts

Annual EPS Est (Dec-14) :3.16
Quarterly EPS Est (Sep-14) :0.77
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.55

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback